Corrigendum: Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial

Front Neurosci. 2024 Oct 3:18:1386314. doi: 10.3389/fnins.2024.1386314. eCollection 2024.

Michelle Rissling¹, Lianqi Liu², Shawn D Youngstedt³, Vera Trofimenko⁴, Loki Natarajan^{5

6}, Ariel B Neikrug⁷, Neelum Jeste⁸, Barbara A Parker^{2

6}, Sonia Ancoli-Israel^{1

6}

¹ Department of Psychiatry, University of California, San Diego, San Diego, CA, United States.
² Department of Medicine, University of California, San Diego, San Diego, CA, United States.
³ Edson College of Nursing and Health Innovation, Arizona State University, Phoenix, AZ, United States.
⁴ St. Joseph Hospital, Orange, CA, United States.
⁵ Family Medicine and Public Health, University of California, San Diego, San Diego, CA, United States.
⁶ Moores Cancer Center, University of California, San Diego, San Diego, CA, United States.
⁷ Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, United States.
⁸ Johnson & Johnson, San Diego, CA, United States.

Abstract

[This corrects the article DOI: 10.3389/fnins.2022.815872.].

Keywords: PSQI; actigraphy; activity; breast cancer; light therapy; sleep.